Cytoflex LX system
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700682P
- Awardee
-
Beckman Coulter, Inc. UEI Z4DRFM3LMJB8 Part of Danaher Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $263,920
Award facts
- Opportunity
-
- N02CO7270578 Solicitation number
- CytoFLEX LX flow cytometer, or equal Award Notice · Posted Sep 11, 2017
- Contract value 100% obligated
- $263,919.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Brea, CA 92821, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Beckman Coulter, Inc. for a CYTOFLEX LX System with a ceiling value of $263,919.80, effective September 18, 2017 with ultimate completion November 17, 2017. No set-aside was used. Place of performance is Brea, California. The order is firm fixed price.
Quick answers
Who was awarded contract HHSN261201700682P?
HHSN261201700682P was awarded to Beckman Coulter, Inc. by National Cancer Institute (National Institutes of Health) on September 18, 2017.
How much is contract HHSN261201700682P worth?
The government has obligated $263,920 on HHSN261201700682P.
Was contract HHSN261201700682P competed?
The extent of competition for HHSN261201700682P was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award